That is the silver lining. The 70M trade secret claim for relief does hurt though
Jeffrey analyst Cohen added ... “As a result of the announcement, and until we are able to garner more pertinent information from various parties regarding the company's path ahead, we are reducing our rating from Buy to Neutral with no current associated price target,” Cohen commented.
They will explore options regarding post-trial motions in the trial court and, potentially, the appellate process.
B_roberts, I will give you your dues. Good call. I am out of TRKK, but have an eye on it.
The dilutions has obviously played a part here. But the earnings news was very encouraging. The question is, what is the balance point between the impact of dilution and the prospects of future revenue growth?
You can short stocks under $5 and YES you can short OTC and Pink Sheet stocks. Not all brokers allow it though.
So get your facts right before name calling. OR are you just a short. Come on,... screaming dilution and other P&D. Douth protest too much. Hmmm....
I agree. Its shorts who are yelling pump and dump. Why would anyone care otherwise. Shorts are definitely at risk tomorrow morning.
I agree with retracing, but the other way. It will retrace it way back to .90+, were it was in January. TRKK will be back up to its previous reading range before the last 4 month fall. Then we can see where it goes from there.
David Phipps, Chief Executive Officer of Orbital Tracking Corp. "As now being demonstrated in our financial results, our continued growth in product sales is producing a meaning shift in our business, one towards higher-margin, recurring revenue based on airtime usage from our growing customer base. Looking ahead to the remainder of 2016, we have reason to be optimistic that demand for our products remain strong and that top line revenue will to grow while margins continue to improve."
TRKK has passed a couple of more potential resistance points. Very impressive!
Some posters (panic shorts I am guessing) are trying to say this is a pump and dump. TRKK came out with very strong earnings for a small float stock. People are just now figuring out how strong TRKK will be and are jumping on it.
That is not a pump and dump. If you want to look at a real pump and dump, look at APHD. APHD was .01 on Friday. They announced a new contract, but did not provide any details. That went from .01 to over .20 without any details. Now APHD is .12 and fading. APHD was a true pump and dump. TRKK should not be confused with that.
Not only is TRKK way above daily volume, but the bid/ask volume size is crazy high!!
Interest right now is intense! .20 looks like the launching point.!
TRKK just moved past the 1st resistance point on a volume spike. Volume is sustaining. .95 stock in January. The fall from .95 over the last months has few resistance/support levels. So it will be interesting to see how high this trades over the next 1-2 weeks.
The float is about 36M...institutions own about 2.5Million shares (6.6%)
The avg trading volume is 336,00 and today's volume so far is 5,300,000.
It is not hard to see what is happening. Institutions are selling a typically low volume stock this morning driving this down sharply. It will take a while to recover. THere is value here at these levels , but this morning if you are buying you are swimming into a strong current.
I am guessing institutional selling is the reason for the pressure this morning. Not sure when institutional selling will subside,
Guidance reduced $76 to $81 million, from $84 to $87 million. How is that horrible?? Not good, true. But horrible it is not.
The combination of the CEO leaving and the low float makes AH prices a very interesting entry point.
The Company expects that Dr. Lang will remain the CEO until the successor has been appointed and Dr. Lang will continue to serve on the Board of Directors.
Its funny to read other posts like "CEO Bailing". Sounds like Lang is still part of the team, but just doesn't want to run it.
There is always initial panic when a CEO leaves.Overall, numbers were not bad enough to justify the AH drop. But low float low volume causes this type of wild swing.
Ok, you got me to read your article. Nice thorough job of providing a primer for us laymen on drug labling and KMPH's prospects.
for 3.7m for the year that is about 900k qtr. So that is a flattening out if you go back and put the 2014 numbers in. The growth from 2014 to Q3 of 2015 was very good.
Well, flattening may be a little exaggerated, but the upward trend is gradual and rather methodical. Not a bad thing. But I am dissappointed that TAPM has stayed in such a tight range.
I get it. not a good quarter...again. But I am shocked that a lot of this hasn't been baked in already.
Bad, yes. But a 25% walloping AH?? wow, I am not sure that the baby is not being thrown out with the bath water here. Parts of Endo's business are worth more than this. (sum of parts are greater than the whole).
I am an AH Buyer. I know it can get worse in the AM, but this is pretty extreme given that a revenue/EPS reduction should have been expected.